Karyopharm Therapeutics Inc. (KPTI)
NASDAQ · Manufacturing · Pharmaceutical preparations
$1.66−$0.0700 (−4.05%) on the dayAs of the close; data may be delayed.
KPTI price, last 12 months
Key stats
- Previous close
- $1.73
- Open
- $1.73
- Day range
- $1.57 – $1.77
- 52-week range
- $1.24 – $10.99
- Volume
- 1.4M
- Avg volume (20 days)
- 1.4M
- Market cap
- $36.7M
Performance
1W−11.7%
1M−15.3%
3M−83.7%
6M−70.2%
YTD−77.5%
1Y−75.9%
vs S&P 500, 1Y−92.7 pts
Technicals and fundamentals
About Karyopharm Therapeutics Inc.
Karyopharm Therapeutics Inc is a commercial-stage pharmaceutical company focused on novel cancer therapies and dedicated to the discovery, development, and commercialization of drugs directed against nuclear export for the treatment of cancer and other diseases. The company conducts research focused on intracellular communication between the nucleus and cytoplasm and has developed small-molecule compounds that inhibit exportin 1 (XPO1), a nuclear export protein. It is focused on marketing XPOVIO (selinexor).
- Sector
- Manufacturing
- Industry
- Pharmaceutical preparations
- Listed on
- NASDAQ
- Market cap
- $36.7M